Abstract
To the Editor.— In their article on immunological disturbances in psychiatric patients, Roos et al 1 found no changes in immunoglobulin levels in schizophrenics and depressed patients, which suggested to them that viral and autoimmune factors were not of etiological significance in these conditions. Eighty-two percent of the sample population in this study was composed of schizophrenic patients who had been exposed to neuroleptics for prolonged periods of time. Gowdy 2 has shown that neuroleptics affect immunoglobulin levels. Furthermore, although these patients had been drug-free for two weeks before specimens were obtained, active metabolites of these drugs can still be present in the tissues for up to 60 days or longer. 3,4 What effect this would have on immunological criteria is uncertain. To avoid this problematic effect, the sample population should ideally be composed only of patients who have never taken neuroleptics.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.